Jeito Capital
Biotechnology · Venture Capital
$104.9Mraised by its portfolio in 12 months
9open roles in its portfolio
23investments
6exits
Overview
Jeito Capital is a biotech venture fund built around a patient benefit approach to investing. It finances breakthrough medical innovation in private biopharmaceutical companies across Europe and the United States, supporting them from early development to late clinical stages. The firm was founded in Paris in 2019 by Rafaele Tordjman, a physician and long-time life sciences investor.
Investor profile
Venture capitalInvestments
23
11 of them startups
Hiring now
3
9 open roles
Rounds in 12 months
3
$104.9M raised
Exits
6
Focusshare of its companies
Health Care 93%Biotechnology 33%
Where its companies are
United States 17%United Kingdom 4%Germany 4%Switzerland 4%France 4%
Stage of its companies
Series A 67%Series B 33%
Its companies, the freshest money firstAll 23 investments
SparingvisionVenture round $48.1M · this month
Quell Therapeutics LtdVenture round · 7 mo ago
AlveusVenture round $56.9M · 10 mo ago
ReproNovoSeries A $65M · 17 mo ago · led a round
Alentis TherapeuticsSeries D $181.4M · 23 mo ago
Noema PharmaSeries B · 23 mo ago · 1 role
Augustine TherapeuticsSeries A $18.4M · 2 yr ago
CorteriaSeries A $70.7M · 3 yr ago · led a round
PulmocideVenture round $52M · 3 yr ago
NMD PharmaVenture round $37.8M · 4 yr ago
Merck.comVenture round $486 · 5 yr ago · 4 roles
Catalym5 roles
Hiring fastestroles opened in 30 days
Co-investorscompanies they hold together
Similar investorstheir companies share markets and countries
Sources: its portfolio page, read Nov 3; 3 rounds in the press that name it
People

Sabine Dandiguian Moumdjian
Directeur Général

Rafaele Tordjman
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ
Select Page
10-50 est. staff
37 rue de la Victoire, 75009 PARIS

Omega Funds
OrbiMed
RA Capital Management
Ysios Capital
SR One
Sofinnova Investments
V-Bio Ventures
AdBio
Longitude Capital
Novartis Venture Fund
venBio Partners
Pontifax